Lv2
140 积分 2024-04-07 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
3个月前
已完结
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
3个月前
已完结
From Challenges to Solutions: A Review of Fourth-Generation EGFR Tyrosine Kinase Inhibitors to Overcome the C797S Triple Mutation in Non-Small Cell Lung Cancer
4个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
4个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
4个月前
已完结
A clinical review on third and fourth generation EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
4个月前
已完结
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
4个月前
已完结
Adagrasib versus docetaxel in KRAS
7个月前
已完结
Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment
9个月前
已完结
皖公网安备34019202002308
